A study of clinicopathologic factors as indicators for early prediction of suboptimal debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer-Reference-Cited by-同舟云学术

A study of clinicopathologic factors as indicators for early prediction of suboptimal debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer

Published:2018-04-23 Issue:7 Volume:44 Page:1294-1301
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Son Joo-Hyuk¹,Chang Kyoungjin²,Kong Tae-Wook¹,Paek Jiheum¹,Chang Suk-Joon¹,Ryu Hee-Sug¹

Affiliation:

1. Division of Gynecologic Oncology; Ajou University School of Medicine; Suwon Korea

2. Department of Obstetrics and Gynecology; Ajou University School of Medicine; Suwon Korea

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jog.13653/fullpdf

Reference32 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Role of aggressive surgical cytoreduction in advanced ovarian cancer;Chang;J Gynecol Oncol,2015

3. Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis;Chang;Gynecol Oncol,2013

4. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N Engl J Med,2010

5. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): An open-label, randomised, controlled, non-inferiority trial;Kehoe;Lancet,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant chemotherapy for high-grade serous ovarian cancer: radiologic–pathologic correlation of response assessment and predictors of progression;Abdominal Radiology;2024-03-13

2. Importance of Laparoscopy in Predicting Complete Cytoreduction at Advanced Stage Ovarian Cancer;Indian Journal of Gynecologic Oncology;2022-10-29

3. Association between Energy Balance-Related Factors and Clinical Outcomes in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis;Cancers;2022-09-20

4. Extreme skeletal muscle loss during induction chemotherapy is an independent predictor of poor survival in advanced epithelial ovarian cancer patients;Journal of Obstetrics and Gynaecology Research;2020-10-04

5. Associations between metabolic syndrome and gynecologic cancer;Obstetrics & Gynecology Science;2020-05-15